ConductScience.org, home

Paper41002483

Development of an Innovative Nanosystem Based on Functionalized Albumin and Oxidized Gellan for the Synergistic Delivery of Curcumin and Temozolomide in the Treatment of Brain Cancer.

Iurciuc Tincu CE and 11 others. Gels, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Development of an Innovative Nanosystem Based on Functionalized Albumin and Oxidized Gellan for the Synergistic Delivery of Curcumin and Temozolomide in the Treatment of Brain Cancer. Papers, record 41002483. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41002483

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of an Innovative Nanosystem Based on Functionalized Albumin and Oxidized Gellan for the Synergistic Delivery of Curcumin and Temozolomide in the Treatment of Brain Cancer.
PubMed
Journal
Gels
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-09-28
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iurciuc Tincu CECamelia Elena
2Vochița GGabriela
3Gherghel DDanielahttps://orcid.org/0000-0002-9601-7928
4Mihai CTCosmin-Teodorhttps://orcid.org/0000-0002-0945-5437
5Vasiliu SSilvia
6Racoviță ȘȘtefaniahttps://orcid.org/0000-0001-9653-707X
7Cadinoiu ANAnca Niculinahttps://orcid.org/0000-0002-3708-3992
8Logigan CLCorina Lenuțahttps://orcid.org/0000-0002-4494-3583
9Hamcerencu MMihaelahttps://orcid.org/0000-0002-5157-2952
10Mitu FFlorin
11Popa MMarcelhttps://orcid.org/0000-0003-4929-0830
12Ochiuz LLăcrămioarahttps://orcid.org/0000-0001-6447-0958

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References119

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128747713Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433).Sci Rep2017https://conductscience.org/library/papers/28747713PubMed
226037706
Polymeric micelles based on poly(ethylene oxide) and α-carbon substituted poly(ɛ-caprolactone): An in vitro study on the effect of core forming block on polymeric micellar stability, biocompatibility, and immunogenicity.
Colloids Surf B Biointerfaces2015https://conductscience.org/library/papers/26037706PubMed
328280335Nanoparticle abraxane possesses impaired proliferation in A549 cells due to the underexpression of glucosamine 6-phosphate N-acetyltransferase 1 (GNPNAT1/GNA1).Int J Nanomedicine2017https://conductscience.org/library/papers/28280335PubMed
436839945The Effect of Curcumin-Loaded Glucan Nanoparticles on Immune Cells: Size as a Critical Quality Attribute.Pharmaceutics2023https://conductscience.org/library/papers/36839945PubMed
525148603Albumin hydrogels formed by electrostatically triggered self-assembly and their drug delivery capability.Biomacromolecules2014https://conductscience.org/library/papers/25148603PubMed
628150932Biomimetic Human Serum Albumin Nanoparticle for Efficiently Targeting Therapy to Metastatic Breast Cancers.ACS Appl Mater Interfaces2017https://conductscience.org/library/papers/28150932PubMed
725356469
1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987.
J Control Release2014https://conductscience.org/library/papers/25356469PubMed
829329242Absorption and Metabolism of Phenolics from Digests of Polyphenol-Rich Potato Extracts Using the Caco-2/HepG2 Co-Culture System.Foods2018https://conductscience.org/library/papers/29329242PubMed
917371541Potential functional role of plasmacytoid dendritic cells in cancer immunity.Immunology2007https://conductscience.org/library/papers/17371541PubMed
1027299311Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.Pharm Res2016https://conductscience.org/library/papers/27299311PubMed
1139005962Albumin Nanoparticle-Based Drug Delivery Systems.Int J Nanomedicine2024https://conductscience.org/library/papers/39005962PubMed
1225003794Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.J Control Release2014https://conductscience.org/library/papers/25003794PubMed
1331540426Aptamer-Functionalized Liposomes as a Potential Treatment for Basal Cell Carcinoma.Polymers (Basel)2019https://conductscience.org/library/papers/31540426PubMed
1435209225Thermodynamic Solubility Profile of Temozolomide in Different Commonly Used Pharmaceutical Solvents.Molecules2022https://conductscience.org/library/papers/35209225PubMed
1531261723In Silico Prediction of PAMPA Effective Permeability Using a Two-QSAR Approach.Int J Mol Sci2019https://conductscience.org/library/papers/31261723PubMed
1610869357Substrate specificity in the highly heterogeneous M4 peptidase family is determined by a small subset of amino acids.J Biol Chem2000https://conductscience.org/library/papers/10869357PubMed
1722029860Molecular switch for the assembly of lipophilic drug incorporated plasma protein nanoparticles and in vivo image.Biomacromolecules2012https://conductscience.org/library/papers/22029860PubMed
189278892Stability of curcumin in buffer solutions and characterization of its degradation products.J Pharm Biomed Anal1997https://conductscience.org/library/papers/9278892PubMed
1930176744Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting.Drug Deliv2018https://conductscience.org/library/papers/30176744PubMed
2029670967Investigation of HSA as a biocompatible coating material for arsenic trioxide nanoparticles.Nanoscale2018https://conductscience.org/library/papers/29670967PubMed

See all 119 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
FPR12357PubTator's text mininghttps://conductscience.org/library/genes/2357NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41002483

GET https://conductscience.org/api/papers/v1/41002483/references?page=2